Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Observation
Locations
5
China
Xuanwu Hospital Capital Medical University
Beijing, Beijing Municipality, China
Beijing hospital
Beijing, Beijing Municipality, China
Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, University of Chinese Academy of Sciences (UCAS)
Chongqing, Chongqing Municipality, China
Tongji Hospital affiliated to Tongji Medical College of Huazhong University
Wuhan, Hubei, China
Eastern Hepatobiliary Surgery Hospital, Second Military Medical University
Shanghai, Shanghai Municipality, China
Start Date
December 20, 2021
Primary Completion Date
March 17, 2023
Completion Date
March 17, 2023
Last Updated
February 23, 2024
NCT07175441
NCT04891289
NCT05969860
NCT06427941
NCT05842174
NCT07164313
Lead Sponsor
Geneplus-Beijing Co. Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions